DSM Venturing helped extend the cartilage replacement technology startup's series A round, augmenting a $16m first close featuring Johnson & Johnson.

Dingdang Medicine Express has secured further funding from repeat backer SoftBank China Venture Capital, while a healthcare fund backed by Sinopharm also took part in the round.

Chicago’s endowment participated in the series A, following a $1.1m seed round last year that included prize money from the Chicago-run New Venture Challenge.

HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.

Building on work at MIT’s Koch Institute of Integrative Cancer Research, Elicio hopes to begin patient studies in 2020 for pancreatic, colorectal, head and neck cancers.

Founded by a former research engineer from regional TTO Satt AxLR, genetic analysis platform company SeqOne has become one of the first businesses to be backed by the PSL Innovation Fund.

Johnson & Johnson Innovation – JJDC, IP Group and CIC have returned for a $52.2m series B round for Inivata, a spinout of Cancer Research UK and University of Cambridge.

The corporate-backed online pharmacy is in discussions with SoftBank over a $100m round that would potentially value it at $400m.

IP Group, CIC and Johnson & Johnson have returned for a $52.2m series B round in Inivata, a spinout of Cancer Research UK and University of Cambridge.

Liverpool's health sciences academic assessment software spinout has been bought by exam platform ExamSoft, which will augment and integrate its services.